Ligand · 06S

06S · O-[(2R,3S,4R,5R)-5-(2-amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-2-({[(S)-({(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-hydroxy-2-[(thiophosphonooxy)methyl]tetrahydrofuran-3-yl}oxy)(sulfanyl)phosphoryl]oxy}methyl)-4-hydroxytetrahydrofuran-3-yl] dihydrogen (S)-phosphorothioate

06S, O-[(2R,3S,4R,5R)-5-(2-amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-2-({[(S)-({(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-hydroxy-2-[(thiophosphonooxy)methyl]tetrahydrofuran-3-yl}oxy)(sulfanyl)phosphoryl]oxy}methyl)-4-hydroxy…

Component: 06S
Formula: C19 H26 N7 O16 P3 S3
Class: ligand
Structures: 2
PDB entries: 1

Binding sites

06S in 2 structures; the first of them:

4R09 · Crystal structure of human TLR8 in complex with ORN06S · 06S A902 · binds TYR291, LYS314, VAL315, GLU340, ILE341, ASP343, SER345, HIS373 and 8 more
4R09 · Crystal structure of human TLR8 in complex with ORN06S · 06S A902 · binds TYR291, LYS314, VAL315, GLU340, ILE341, ASP343, SER345, HIS373 and 8 more

Residues it binds most

ARG 8, ASN 8, HIS 8, ASP 8, GLU 8, ILE 8, LEU 8, LYS 8, PHE 8, THR 8 (residue and the binding sites it lines).

Found with

UPT · 1-[(2R,3aR,4R,6R,6aR)-2-hydroxy-6-(hydroxymethyl)-2-sulfidotetrahydrofuro[3,4-d][1,3,2]dioxaphosphol-4-yl]pyrimidine-2,4(1H,3H)-dione
URI · Uridine
BMA · beta-D-mannopyranose
MAN · alpha-D-mannopyranose
NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.